Europe Approves Western World’s First Stem-Cell Therapy for Rare Eye Condition

February 23, 2015

(Reuters) – Europe has approved the Western world’s first medicine containing stem cells to treat a rare condition caused by burns to the eye, marking a milestone in the use of the technology. Holoclar, from privately held Italian company Chiesi, was given a marketing green light on Friday by the European Commission for treating so-called limbal stem cell deficiency due to physical or chemical burns.